- Lobbying
- Lobbying by electroCore
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeffery Mortier | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes Prof Staff on E&C Cmte LA Rep Whitfield and Intern Devin Nunes |
Jeff MacKinnon | LD & LA Rep. Joe Barton (RTexas) |
Sarah Walter | Former Legislative Director/Chief Counsel, Sen. John Breaux Former Legislative Director/Chief Counsel, Sen. John Breaux |
Edward Whitfield | U.S. Representative (21 yrs.) |
Kristen O'Neill | Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX) Staff Assistant GK Butterfield (D-NC) Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX) Staff Assistant GK Butterfield (D-NC) |
J. Daniel Walsh | LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
William Krieger | n/a |
Jody Gale | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Veterans Affairs - Dept of (VA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
White House Office
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
White House Office
Office of Science & Technology Policy (OSTP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to medicare coverage and reimbursement. Issues related to the opioid legislation..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate